- Re-evaluating the PCSK9 guidelines for low-density lipoprotein cholesterol targets: weighing the benefits against the risks
-
Gbaa T, Bolodeoku J
- KMID: 2558118
- Cardiovasc Prev Pharmacother.
- 2024 Jul;6(3):85-91.
- doi: 10.36011/cpp.2024.6.e11
Cardiovascular disease management has made significant progress with lipid-lowering interventions, primarily statin therapy. However, statins' side effects, combined with their variable efficacy, have sparked interest in alternative treatments, particularly proprotein... -
- CITED
-
- Close
- SHARE
-
- Close
